Skip to content
Home/Companies/Biotech/Gandeeva Therapeutics
GT

Gandeeva Therapeutics

Biotech·Canada·Active·4yr hold

Gandeeva Therapeutics is a biotech company, headquartered in Canada.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Gandeeva Therapeutics?

Gandeeva Therapeutics is currently owned by Leaps by Bayer through Leaps by Bayer (2015 vintage), since 2022.

Hand-verified · updated 2026-07-16

Leaps by Bayer
Investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen

Key facts

HQCanada
SectorBiotech
StatusActive

More from Leaps by Bayer

Other portfolio companies in the same fund.

Celea Therapeutics
Active
BiotechUnited States· 2026
Leaf Agriculture
Active
ClimateTechUnited States· 2026
Sabanto
Active
AgTechUnited States· 2026
SonoThera
Active
BiotechUnited States· 2026
Souffle Therapeutics
Active
BiotechUnited States· 2025
WellTheory
Active
HealthTechUnited States· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings